Longevity Research

关注
Split-image illustration of frail elderly male lab mice before and after drug treatment extending lifespan by 73%, with UC Berkeley lab setting.
AI 生成的图像

Drug combo extends remaining lifespan of frail elderly male mice by about 70%

由 AI 报道 AI 生成的图像 事实核查

A combination of oxytocin and an Alk5 inhibitor significantly extended remaining lifespan and improved health in very old, frail male mice, according to research from the University of California, Berkeley. The treatment increased their remaining life by about 73% but did not lengthen lifespan in females, underscoring key sex differences in aging biology and in responses to longevity therapies.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝